lolium perenne pollen
Allergenapproved
Approved
Mar 13, 1924
Lolium perenne, common name perennial ryegrass, English ryegrass, winter ryegrass, or ray grass, is a grass from the family Poaceae. It is native to Europe, Asia and northern Africa, but is widely cultivated and naturalised around the world. — Wikipedia
Clinical trial activity
8 trials · 16 clinical orgs · 4 marketing orgs
Phase 1
3
Phase 2
6
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00813046)
Timeline
1920s
- Mar 13, 1924
Jubilant Innovation Ltd. — Earliest FDA Approval
- Mar 13, 1924
Jubilant Innovation Ltd. — NDA Secondary Org
- Mar 13, 1924
Jubilant Innovation Ltd. — NDA Organization
1930s
- Jun 14, 1930
Allermed Laboratories — NDA Secondary Org
- Jun 14, 1930
Greer Laboratories — NDA Secondary Org
- Jun 14, 1930
ALK-Abello, S.A. — NDA Secondary Org
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Lolium perenneImmunity, desensitized
Lolium perenne immunity, desensitized
Approval history
- approvedMar 13, 1924
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLolium perenne ↗
- NCATS7C82Y2EF9V ↗
- WikipediaLolium_perenne ↗
- NCATS4T81LB52R0 ↗
Also known as
- gpasit+
- lolium allergen extract
- pollens - grasses ryegrass perennial lolium perenne
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02560948 | Phase 3 | Dec 1, 2015 | ASIT Biotech S.A., Universitair Ziekenhuis Gent, University of Milan, University of Pilsen, University of Strasbourg |
| NCT02156791 | Phase 2 | Aug 1, 2013 | ASIT Biotech S.A. |
| NCT01506375 | Phase 2 | Nov 1, 2011 | ASIT Biotech S.A. |
| NCT01394289 | Phase 2 | Sep 1, 2011 | Leti Pharma GmbH |
| NCT01308021 | Phase 2 | Dec 1, 2010 | ASIT Biotech S.A., AZ Sint-Lucas, Centre Hospitalier de Luxembourg, CH de Dinant, CHR Warquignies, Free University of Brussels, Katholieke Universiteit Leuven, Universitair Ziekenhuis Gent, University of Antwerp, University of Lille, University of London, University of Reims, University of Strasbourg |
| NCT01111279 | Phase 1 | Mar 1, 2010 | ASIT Biotech S.A., Katholieke Universiteit Leuven |
| NCT00833066 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2009 | ASIT Biotech S.A. |
| NCT00813046 | Phase 1 | Dec 1, 2008 | ASIT Biotech S.A. |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ASIT Biotech S.A. | For profit | 7 | 7 | 3 | 2008 |
| Katholieke Universiteit Leuven | Academic/Hospital | 2 | 0 | 2 | 2010 |
| Universitair Ziekenhuis Gent | Academic/Hospital | 2 | 0 | 2 | 2010 |
| University of Strasbourg | Academic/Hospital | 2 | 0 | 2 | 2010 |
| AZ Sint-Lucas | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Centre Hospitalier de Luxembourg | Academic/Hospital | 1 | 0 | 1 | 2010 |
| CH de Dinant | Academic/Hospital | 1 | 0 | 1 | 2010 |
| CHR Warquignies | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Free University of Brussels | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Leti Pharma GmbH | For profit | 1 | 1 | 1 | 2011 |
| University of Antwerp | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Lille | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Milan | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Pilsen | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Reims | Academic/Hospital | 1 | 0 | 1 | 2010 |
16 organizations
Page 1 / 1
Marketing (5)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| ALK-Abello, S.A. | For profit | NDA2 | Jun 14, 1930 |
| Allermed Laboratories | For profit | NDA2 | Jun 14, 1930 |
| Greer Laboratories | For profit | NDA2 | Jun 14, 1930 |
| Jubilant Innovation Ltd. | For profit | NDA2 | Mar 13, 1924 |
| Jubilant Innovation Ltd. | For profit | NDA | Mar 13, 1924 |